Arbeit Robert D. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Dec 7, 2011
Insider Transaction Report
Form 4
Arbeit Robert D.
VP Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2011-12-05+37,500→ 37,500 totalExercise: $1.16From: 2012-11-28Exp: 2021-11-28→ Common Stock (37,500 underlying) - Award
Stock Option (Right to Buy)
2011-12-05+37,500→ 37,500 totalExercise: $1.16Exp: 2021-11-28→ Common Stock (37,500 underlying)
Footnotes (2)
- [F1]The various numbers listed in Columns 5, 7 and 9 relate to a single option grant which entitled the reporting person to purchase up to an aggregate of 150,000 shares of the issuer's common stock. The option to purchase the remaining 75,000 shares of the issuer's common stock is subject to satisfaction of performance-based vesting criteria.
- [F2]The option vests over four years in 16 equal quarterly installments beginning on February 28, 2012.